Status:
UNKNOWN
Improve Functional Health Status in Minority Women With HIV
Lead Sponsor:
Seton Hall University
Conditions:
HIV/AIDS
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
HIV is no longer a death sentence, and with adherence to Rapid High Activity Antiretroviral (HAART) protocol women with HIV can achieve a normal life expectancy. In New Jersey there are 11,724 (32.9%)...
Detailed Description
Background: Among the more than one million persons in the United States living with HIV/AIDS, women comprise approximately 25% or 280,000 of persons infected with HIV (CDC, 2015). According to The CD...
Eligibility Criteria
Inclusion
- Women participants diagnosed with HIV
- Must speak and write in English
Exclusion
- Women participants with debilitating complications
- Women participants with Cognitive Impairment
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04315675
Start Date
April 1 2020
End Date
December 31 2020
Last Update
March 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seton Hall University, College of Nursing
Nutley, New Jersey, United States, 07110